Savient Pharmaceuticals, Inc. (SVNT) Misses Q2 Loss Views by 13c
Tweet
Share
E-mailGet Alerts SVNT Hot Sheet
Price: $40.05 --0%
Financial Fact:
Investment income, net: 9K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Investment income, net: 9K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) reported Q2 EPS of ($0.43), $0.13 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $2 million versus the consensus estimate of $2.77 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
- The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
